logo
2026 Jeep Grand Cherokee Teased with Tweaked Front End and Cabin

2026 Jeep Grand Cherokee Teased with Tweaked Front End and Cabin

Yahoo08-05-2025

Jeep teased a refreshed 2026 , which will be revealed in full later this year.
The mid-size SUV gets revised front-end styling with updated headlights and reworked grilles.
The cabin is largely the same but features simplified climate controls and smaller knobs that now live on either side of the touchscreen.
The Jeep Grand Cherokee is the American brand's bestseller, but it's in need of an update. The latest generation arrived for the 2021 model year as the three-row Grand Cherokee L before adding a two-row variant for 2022. Last year, sales of the SUV declined 12 percent to 216,148 units (down from 244,594 sales in 2023). Luckily, Jeep is readying a refresh for the mid-size SUV, releasing two teaser images for the 2026 Grand Cherokee today that show a glimpse of its reworked styling and cabin.
The changes to the Grand Cherokee's front end are subtle but significant. The headlights sport a new hockey-stick-shaped LED strip along the top edge that curves down to meet the upturned chrome trim that links the grille to the bottom of the headlight. The grille also has a new look with reworked silver trim that seems to take inspiration from the recently revealed Jeep Compass EV, currently only destined for Europe.
The front bumper has been thoroughly redesigned, splitting the lower air intake into two separate elements. The top section is linked to the side vent via the daytime running light, while the chrome strip along the bottom of the lower grille now curves upwards at the outer edge of the front fascia. Anecdotally, we recently spotted a prototype of the refreshed Grand Cherokee in the Detroit area, and the camouflage was concentrated on the front, suggesting that the rear styling could remain largely unchanged.
The cabin is also restyled, most notably on the center console, where the bank of climate-control buttons below the central touchscreen has been simplified into a single row of buttons. The two knobs are now smaller and live higher up, sitting on either side of the screen along with a few other buttons. The passenger screen also looks like it may have grown in size, but we'll have to wait for more details from Jeep before we can say for sure.
Jeep says the Grand Cherokee will continue to be built at Stellantis' plants in Detroit and will continue to offer both the two-row and three-row L models, as well as the plug-in hybrid 4xe powertrain. More information about the 2026 Jeep Grand Cherokee will emerge later this year.
You Might Also Like
Car and Driver's 10 Best Cars through the Decades
How to Buy or Lease a New Car
Lightning Lap Legends: Chevrolet Camaro vs. Ford Mustang!

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

Yahoo

time34 minutes ago

  • Yahoo

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera ( in Delaware to expand its presence in the U.S. market. A Pre-IND application was submitted to the FDA. The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on PolTREG's Pediatric Investigation Plan (PIP) for PTG-007 in pre-symptomatic type 1 diabetes (Stage 1). Gdańsk, Poland – 13 JUNE 2025 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, announces that it has established a wholly owned subsidiary, Immuthera, a United States C Corporation, in the state of Delaware. This is a further step by PolTREG to deepen its entry into the U.S. market. 'Over recent years, PolTREG has created a platform for the development of multiple cellular therapies: polyclonal Tregs, CAR-TREGs, mulit-eidited/allogeneic CAR-Tregs, antigen-specific Tregs, and mRNA immunotherapies, all informed by our clinical experience. To fully leverage our potential, we are focusing on the execution our growth strategy in the American market by systematically bringing existing therapies, and exploring new assets into the US. We have established partnerships with several renowned entities such as Noble Capital Markets, Inc., for strategic and financial advisory services. We have also formed a strategic cooperation with the Swiss company Antion Biosciences to develop the next generation of allogeneic TREG therapies' said Prof. Piotr Trzonkowski, CEO of PolTREG. 'This expands PolTREG's project pipeline and enhances the company's attractiveness to potential strategic partners. Additionally, we with the U.S. company Kinexum Services LLC for strategic advisory regarding Immuthera's interactions with the FDA and the registration of TREG therapies in the United States. We submitted our Pre-IND meeting request to the FDA in mid-May,' added Prof. Piotr Trzonkowski. PolTREG is currently in discussions with leading American academic and clinical centers to establish collaborations and evaluate new technologies Immuthera has also begun the process of building a world-class Scientific Advisory Board comprised of globally recognized leaders in the Autoimmune and Neuroinflammatory disease. In support of PolTREG and the launch of Immuthera, Dr. Dan Shelly, Chief Business Development Officer, and Dr. Mariusz Jablonski, Chief Business Officer, will participate in the upcoming BIO International Convention 2025, taking place from June 16–19 in Boston. At BIO Drs. Shelly and Jablonski will be promoting PolTREG's current clinical and developmental pipeline while also speaking to potential partners, collaborators, and investors for Immuthera. In May, the Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on the Pediatric Investigation Plan (PIP) for PolTREG's investigational somatic cell therapy product, polyclonal Treg lymphocytes (PTG-007), which is aimed to prevent symptomatic type 1 diabetes in children. The PDCO's positive opinion is based on PolTREG's original preTreg clinical trial protocol, initiated in October 2024, enrolling children aged 6–16 years with Stage 1 type 1 diabetes. In its assessment, the committee recommended broadening the eligible population to include patients aged 3–18 years suggesting that the agency believes this therapy is extremely safe. This positive opinion paves the way for potential marketing authorization in the EU. To read more about the clinical trials PolTREG has completed, please click on: PolTREG manufactures its Treg therapeutics at its own GMP-certified manufacturing facility. It is the first company in the world to have administered Treg therapies to patients, and, under a hospital exemption valid in Poland, the first company to start receiving revenues from a Treg therapeutic for autoimmune disease. Its GMP manufacturing facility is one of Europe's largest and most advanced, boasting over 2,100 sqm of laboratory space, including 15 production lines. PolTREG has the option to substantially expand the facility to accommodate manufacturing of next-generation engineered therapies and cell therapies. It can ship its wide range of cellular therapy products across Europe within 24 hours. About PolTREG PolTREG is a global leader in developing autoimmune therapies based on T-regulatory cells (Tregs). Its lead product, PTG-007, autologous Treg treatment for early-onset Type-1 Diabetes (T1D) is ready for Phase 2/3 clinical testing, for which the company is seeking a partnership. PolTREG has established a robust platform encompassing a wide range of cell therapy approaches, including polyclonal TREG, CAR-TREG, allogeneic TREG, antigen-specific TREG, and TCR-TREG therapies. About Immuthera Immuthera is pioneering novel cell-based therapies for clinical development in the United States and Canada. Immuthera will be clinically developing assets initially developed by PolTREG under the US FDA regulatory framework. Immuthera will have full access to PolTREG's Research and Development capabilities along with the ability to explore novel modalities developed by US Institutions. Immuthera is currently seeking investment to pursue the manufacture and clinical development of these assets in the United States. For more information please visit For further information please contact:PolTREG Piotr TrzonkowskiChief Executive Officerir@ 512 532 401 Important information The contents of this announcement include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes", "estimates," "anticipates", "expects", "intends", "may", "will", "plans", "continue", "ongoing", "potential", "predict", "project", "target", "seek" or "should", and include statements the Company makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. The company's actual results may differ materially from those predicted by the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

Real Matters Inc.'s (TSE:REAL) top owners are retail investors with 60% stake, while 35% is held by institutions
Real Matters Inc.'s (TSE:REAL) top owners are retail investors with 60% stake, while 35% is held by institutions

Yahoo

time34 minutes ago

  • Yahoo

Real Matters Inc.'s (TSE:REAL) top owners are retail investors with 60% stake, while 35% is held by institutions

Significant control over Real Matters by retail investors implies that the general public has more power to influence management and governance-related decisions A total of 25 investors have a majority stake in the company with 41% ownership Institutional ownership in Real Matters is 35% Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Every investor in Real Matters Inc. (TSE:REAL) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 60% to be precise, is retail investors. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Institutions, on the other hand, account for 35% of the company's stockholders. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. In the chart below, we zoom in on the different ownership groups of Real Matters. Check out our latest analysis for Real Matters Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. Real Matters already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Real Matters' historic earnings and revenue below, but keep in mind there's always more to the story. We note that hedge funds don't have a meaningful investment in Real Matters. FMR LLC is currently the largest shareholder, with 10% of shares outstanding. With 10% and 5.0% of the shares outstanding respectively, Manitou Investment Management Ltd. and Jason Smith are the second and third largest shareholders. A deeper look at our ownership data shows that the top 25 shareholders collectively hold less than half of the register, suggesting a large group of small holders where no single shareholder has a majority. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too. The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Shareholders would probably be interested to learn that insiders own shares in Real Matters Inc.. In their own names, insiders own CA$22m worth of stock in the CA$422m company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying. The general public, who are usually individual investors, hold a substantial 60% stake in Real Matters, suggesting it is a fairly popular stock. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions. It's always worth thinking about the different groups who own shares in a company. But to understand Real Matters better, we need to consider many other factors. Be aware that Real Matters is showing 1 warning sign in our investment analysis , you should know about... If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Albertsons, Pavilions, Vons, and Kroger workers set to strike in California
Albertsons, Pavilions, Vons, and Kroger workers set to strike in California

Miami Herald

time43 minutes ago

  • Miami Herald

Albertsons, Pavilions, Vons, and Kroger workers set to strike in California

Strikes only happen when companies push workers past the point of no return. No worker wants to give up a paycheck in order to get the raise and benefits they feel they deserve. In many cases, even when management and labor negotiate a favorable deal, the money lost during a strike remains lost forever. Workers, however, have very little leverage with management when it comes to negotiating fair wages. In many cases, bosses consider workers replaceable and don't take worker demands seriously. In many part of American history, workers could not strike without fear of being replaced. Now, with retail jobs plentiful enough that both Walmart and Target pay their workers over $15 per hour, labor has more leverage. Replacing tens of thousands of people in this market won't be easy, so a strike could cripple the business and do long-term damage. Hopefully, reality forces both sides to come to the table before a work stoppage takes place. Nearly 45,000 Albertsons, Pavilions, Vons, and Kroger (Ralphs) workers have voted overwhelmingly in favor of a strike. They have not walked off the job yet, but the threat to their employers has become very real. UFCW Local 324 represents the impacted workers, and the union has a simple description of its goals. "The mission of UFCW Local 324 is to improve the lives of working families and to bring economic justice to the workplace. The UFCW is one union with one voice. We are committed to changing the places where we work and the communities where we live so that all workers have the opportunity to reach the American Dream," it shared on its website. The union traces its history back to 1936. "The United Food and Commercial Workers union stands as the by-product of mergers between many other trades and professions whose members saw value in uniting in solidarity against an increasingly powerful array of corporate retailers," it added. Now, the union is ready to mobilize its workers to strike. It shared an update on its website. "These past two weeks, nearly 45,000 grocery workers across Southern California came together and overwhelmingly voted YES to authorize an Unfair Labor Practice (ULP) Strike against Ralphs, Albertsons, Vons, and Pavilions for breaking the law by surveilling, interrogating, threatening, and retaliating against union members," it shared. "This vote is a powerful message to Kroger and Albertsons: We are fed up with their union-busting tactics and unlawful behavior that disrespects workers, silences our voices, and stalls progress at the bargaining table." While those are serious charges, the core of the dispute between the workers and management is wages and working conditions. "For four months, we've negotiated with Kroger and Albertsons, offering solutions to the staff shortage crisis that hurts store operations, working conditions, and customer service. The companies have dismissed our proposals and claimed that our concerns were 'anecdotal', downplaying the real challenges we and our customers face daily," the union shared in an update to members. UFCW Local 324 believes it has acted in good faith and that management has not. "We're at the breaking point. We are disrespected, overworked, and undervalued by Kroger and Albertsons. We're tired of asking these corporations to invest in their workers and customers, only to see no results. We're tired of asking the companies to respect our labor rights and seeing our co-workers intimidated," it added. Kroger, which owns Ralphs, shared a statement with KTLA. "Our current offer reflects that commitment, including market-leading wage increases for associates over the life of the agreement, and continued investment in industry-leading healthcare and a pension…These are benefits that many non-union competitors do not offer," a portion of the statement reads. The union has not set a strike date. Negotiations are expected to resume on June 25. The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store